Pharmacy benefit managers offer a wide range of clinical programs designed to improve health outcomes for members, while reducing overall healthcare costs. Plan sponsors may find it challenging to develop a process that effectively evaluates these programs. This paper explores industry best practices plan sponsors can use to consistently assess the value of both new and existing clinical programs.